Bruce HugmanUppsala Monitoring Centre · Patient safety communications
Bruce Hugman
MA (Oxford) MA (Nottingham)
About
39
Publications
9,824
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
279
Citations
Citations since 2017
Publications
Publications (39)
This chapter reviews current research, knowledge and practice in the field of herbal medicines (HMs). Its focus is on phytovigilance, on what has been achieved in the science and the urgent need for its development. As the use of HMs surges across the world, safety and rational use become ever-more pressing issues, especially with regard to the dis...
Pharmacovigilance of herbal medicines, or ‘phytovigilance’, has a major role to play in the discovery and provision of safety information. Communication to mass audiences and individuals about complex scientific issues has always been problematic; communicating herbal medicine safety concerns in general and in relation to their irrational use const...
Signal detection for national pharmacovigilance centres with small data sets 3 The main goal of pharmacovigilance is to ensure the safety of patients. It is the mandate of national pharmacovigilance centres (NCs) to serve as early detectors of any potential harm from medicines. The detection of a signal is an essential step towards achieving this o...
Objectives
• To demonstrate that perceptions of evidence and reality are fundamentally driven by beliefs and values
• To examine the delusional self-confidence of influential figures and the vulnerability of populations in the communication of complex issues
• To review the systems of values and belief that supersede or challenge science and scien...
Objectives
• Examine contemporary processes that undermine the Enlightenment values of reason, science and humanism, as they affect attitudes to science and medicine.
• Assess the impact of the degradation of public discourse in relation to the credibility of evidence and the practice of medicine.
• Propose defensive measures against the assault o...
Pharmacovigilance has not achieved the public profile as a health priority or the impact on patients’ lives that we might have hoped; the vision of comprehensive patient safety, though much stronger since thalidomide, is still far from being realised. Great strides have been made in some regions and institutions, but the overall picture is still de...
Study of the first thirty years of the author's life as he struggles to find his identity and come to terms with his sexual orientation. The story of a post-war baby who evolves from confinement and repression to a state of optimism and freedom.
The purpose of risk communication in clinical practice is to inform and protect; to support wise, balanced and rational decisions that match patients’ wishes and needs, and, in this and the next chapter, particularly those of women. Risk communication touches almost all aspects of our lives. While the quality of the information on which risk commun...
In this chapter we review the detailed issues, questions and skills of risk communication in practice, relevant to medicines for all patients and then focus on challenges of communication with regard to a small selection of medicines for women: anticonvulsants in pregnancy, oral contraceptives, HPV vaccination and Hormone Replacement Therapy (HRT)....
The history and characteristics of bureaucracy1 are examined with a view to understanding the impact of the bureaucratic mindset on medicines' regulation, the pharmaceutical industry and healthcare delivery with a focus on risk communication, pharmacovigilance and patient safety. Controversies and allegations relating to common, negative effects of...
In this narrative review, a brief summary of theoretical approaches to risk perception is followed by an analysis of some of the special factors influencing risk perception and risk communication in sub-Saharan Africa. Examples of recent and emergent local medicines and vaccine controversies in several countries are given along with evidence and an...
The history and characteristics of bureaucracy are examined with a view to understanding the impact of the bureaucratic mindset on medicines’ regulation, the pharmaceutical industry and healthcare delivery with a focus on risk communication, pharmacovigilance and patient safety. Controversies and allegations relating to common, negative effects of...
Robust, active cooperation, and effective, open communication between all stakeholders is essential for ensuring regulatory compliance and healthcare product safety; avoiding the necessity for whistle-blowing; and, most essentially, meeting the transparency requirements of public trust.
The focus here is on what can be done within a healthcare prod...
All communications, especially those intended to influence attitudes and behaviour, depend on the empathy, creativity, and clarity of those responsible for them. Communications of all kinds, in healthcare and other sectors, can be greatly enhanced by the appropriate use of modern media and technology, but at the heart of effective communications ar...
A presentation of the entire range of communication skills needed in healthcare for the achievement of safe and humane patient care and positive, productive professional relationships between all players. Full length book; 300 pages.
The role of misleading or scaremongering news media reports in causing drug crises is well known. Pharmacovigilance systems can play an important educational and preventive role through safety monitoring of products and effective communication about safety issues with health professionals and the general public. That failure to use an existing phar...
The impact of medical litigation and its controversial and damaging consequences are reviewed, along with a number of the proposals for tort and other reforms. As an important effect of the threat of litigation, the practice of defensive medicine is discussed. Proposals are made for improvements in the quality of doctor-patient relationships as a s...
The science of pharmacovigilance--monitoring and evaluating drug safety issues and communicating them effectively--is a vital activity of worldwide significance in the safeguarding of patient welfare and public health. Its clinical, public health and economic importance has been demonstrated, but it needs to be better understood and appreciated by...
Rational use of drugs and patient safety are seriously compromised by a lack of good information, education and effective communication at all stages of drug development and use. From animal trials through to dispensing, there are misconceptions and opportunities for error which current methods of drug information communication do not adequately ad...
The Erice Declaration on Communicating Drug Safety Information, first published in September 1997, provides a vision of vigorous, open, ethical, patient-centred communications in drug safety that the world has yet to achieve. The Declaration is reprinted here as a further stimulus to all parties to renew their commitment and to add new momentum to...
The Erice Declaration on Communicating Drug Safety Information, first published in September 1997, provides a vision of vigorous, open, ethical, patient-centred communications in drug safety that the world has yet to achieve. The Declaration is reprinted here as a further stimulus to all parties to renew their commitment and to add new momentum to...
The core task of the Uppsala Monitoring Centre (UMC) is the collection and processing of adverse drug reaction reports from member countries of the WHO Programme for International Drug Monitoring to detect early signals of potential drug hazards. Also a high priority is the communication of information about drug safety issues to the widest possibl...
The core task of the Uppsala Monitoring Centre (UMC) is the collection and processing of adverse drug reaction reports from member countries of the WHO Programme for International Drug Monitoring to detect early signals of potential drug hazards. Also a high priority is the communication of information about drug safety issues to the widest possibl...
The benefits of good medical science can be maximised only if there is an active commitment to ensuring all the players (including patients) fully understand the practical implications of the science for their lives, and especially the nature of benefit, harm and risk. Communications performance in the area of drug safety has lagged far behind the...
Major changes in UK bus and rail operation have brought benefits and problems. Short-term demands for high returns have led to the slashing of costs and to great productivity improvements. At the same time as there are high levels of investment in new vehicles and upgraded rolling-stock. Marketing and human relations issues have been increasingly m...
Although the techniques involved in drug safety monitoring (pharmacovigilance) have dramatically improved in recent years, communication of these issues to health professionals and the public lags far behind. Several measures need to be taken in order to address this discrepancy.
A climate of greater openness concerning the basis of merit assessmen...
Projects
Project (1)
Improving risk communication practices in the various pharmacovigilance settings world-wide with a view to facilitating informed therapeutic choice, safe use of medicines and credibility of the regulatory system.
Mandate:
to establish risk communication as a sub-discipline of safety surveillance and risk management of medicines,
to provide for multi-disciplinary exchange, learning and practice development and
to promote related research.
